A 1-day non-residential course on
3 October 2013
at the Royal Society of Chemistry,
Burlington House, Piccadilly, London W1J 0BA, United Kingdom
The ‘Falsified Medicines Directive’ (FMD) is one of the most significant pieces of pharmaceutical legislation to arrive for many years! The urgent intention of the FMD is to protect European patients from receiving falsified medicines.
Outlined below are selected reasons why attendance at the Course might be important to position you as a Regulatory or GMP Expert or other person in a role which requires your action, advice or other input into decisions being made for your company’s benefit.
If you are involved with the production of active substances you will need to take serious account of this new legislation and the various means by which its Articles have been, are being and will continue to be applied in the daily life of the global pharmaceutical industry.
In addition and not surprisingly there are many legal changes taking effect that impact on excipients, also to protect the public from falsified medicines.
Most EU companies, aiming to ensure compliance with the new law, face the prospect of carrying out a lot more international and European work. However, it is not just European companies that are affected. This EU legislation has major impacts on a substantial number of parties operating outside the ‘European Community’.
Companies and people involved in the distribution or other movement of pharmaceutical materials from one place to another or those who use, manage, supervise, regulate or give advice about these materials, to make intermediates or finished medicines, face new requirements. That is likely to mean that there are new activities for you to know about and new actions to take.
Unless you are already sure that you understand fully the changes being required, you would be wise to book your place on our new Course. We plan to deliver up-to-date knowledge and understanding to delegates to help them and therefore their companies counteract the menace of falsified medicines.
Please use the links on our site to learn more about the Course. There is information available on the main subject areas of the training, on the excellent panel of speakers and on the delegate package, which is priced to be attractive. You will find it easy to make your booking and you should not delay if you want to ensure a place.
We look forward to meeting you and to sharing a lively programme with good sessions dealing with your questions.